Diamedica Therapeutics Inc (DMAC)

May 05, 2026

MSN Money - MSN

May 05, 2026

May 04, 2026

DiaMedica Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

May 04, 2026

May 03, 2026

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review

May 03, 2026

May 02, 2026

DiaMedica Therapeutics (DMAC) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

May 02, 2026

Apr 30, 2026

DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026 - BioSpace

Apr 30, 2026

Apr 27, 2026

Top Wall Street forecasters revamp DiaMedica Therapeutics expectations ahead of Q4 earnings - MSN

Apr 27, 2026

Apr 24, 2026

DMAC Price Today: DiaMedica Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 23, 2026

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 23, 2026

Apr 23, 2026

DMAC DiaMedica Therapeutics Inc. reports narrower Q4 2025 loss than consensus forecasts, its stock rises modestly in today’s trading.Expert Market Insights - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

Is DiaMedica (DMAC) stock worth committing funds to (Drifts Higher) 2026-04-22Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 16, 2026

DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference - MarketBeat

Apr 16, 2026

Apr 13, 2026

EBITDA per share of DiaMedica Therapeutics Inc. – NASDAQ:DMAC - TradingView

Apr 13, 2026

Apr 13, 2026

Is DiaMedica Therapeutics Inc a cyclical or defensive stock2026 Market Sentiment & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Returns Recap: How does DiaMedica Therapeutics Inc compare to its peers2026 Geopolitical Influence & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 10, 2026

Apr 07, 2026

RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms - marketscreener.com

Apr 07, 2026

Apr 06, 2026

Should I Buy DiaMedica (DMAC) Stock Today | Price at $6.62, Up 2.16%Community Watchlist - Newser

Apr 06, 2026

Apr 03, 2026

Q1 EPS Estimate for DiaMedica Therapeutics Raised by Analyst - MarketBeat

Apr 03, 2026

Apr 03, 2026

What is HC Wainwright’s Forecast for DMAC FY2029 Earnings? - Defense World

Apr 03, 2026

Apr 02, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pharmaceuticals (ORIC) - The Globe and Mail

Apr 02, 2026

Apr 02, 2026

HC Wainwright Issues Pessimistic Estimate for DMAC Earnings - MarketBeat

Apr 02, 2026

Apr 01, 2026

[ARS] DiaMedica Therapeutics Inc. SEC Filing - Stock Titan

Apr 01, 2026

Apr 01, 2026

Equity plan expansion at DiaMedica (NASDAQ: DMAC) adds 3.5M shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

H.C. Wainwright reiterates DiaMedica stock rating on trial progress By Investing.com - Investing.com India

Apr 01, 2026

Apr 01, 2026

H.C. Wainwright reiterates DiaMedica stock rating on trial progress - Investing.com

Apr 01, 2026

Apr 01, 2026

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2026

Mar 31, 2026

DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update - The Globe and Mail

Mar 31, 2026

Mar 31, 2026

DMAC Should I Buy - Intellectia AI

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Inc.Common Stock - FinancialContent

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Reports 2025 Financial Results - National Today

Mar 31, 2026

Mar 31, 2026

DiaMedica reiterates plan for ReMEDy2 interim analysis in 2H 2026 as stroke trial approaches 70% of 200 patients - MSN

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Q4 Earnings Call Highlights - MarketBeat

Mar 31, 2026

Mar 31, 2026

Earnings call transcript: DiaMedica Therapeutics Q4 2025 shows liquidity boost - Investing.com Canada

Mar 31, 2026

Mar 31, 2026

Earnings call transcript: DiaMedica Therapeutics Q4 2025 shows liquidity boost By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights - BioSpace

Mar 31, 2026

Mar 30, 2026

Loss Report: Is DiaMedica Therapeutics Inc a cyclical or defensive stockTrade Analysis Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

DiaMedica Therapeutics (DMAC) Strengthens Financial Position and Advances Clinical Programs - GuruFocus

Mar 30, 2026

Mar 30, 2026

Rising R&D widens loss as DiaMedica (NASDAQ: DMAC) funds DM199 - Stock Titan

Mar 30, 2026

Mar 30, 2026

DiaMedica Therapeutics (NASDAQ:DMAC) Issues Quarterly Earnings Results, Meets Expectations - MarketBeat

Mar 30, 2026

Mar 30, 2026

DiaMedica Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026